Unintended consequences of regulatory initiatives in childhood cancer drug development.
Division of Clinical Pharmacology and Therapeutics, The Children's Hospital of Philadelphia, Pennsylvania.
Peter C
PC
Adamson
D000293:Adolescent; D000970:Antineoplastic Agents / Q000592:standards* / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic; D055808:Drug Discovery / Q000331:legislation & jurisprudence* / Q000592:standards; D005062:European Union; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D014481:United States
D000970:Antineoplastic Agents